Global health and foreign policy: strengthening health system resilience through affordable health care for all A/RES/75/130 14. Calls upon Member States to ensure access to medicines as one of the fundamental elements of a robust health system based on universal health coverage, and reaffirms that States have the primary role and responsibility to d etermine and promote their own path towards achieving universal health coverage that ensures universal and equitable access to quality essential health services and access to safe, effective, quality and affordable essential medicines, vaccines, diagnostic s and other health technologies for all, without discrimination; 15. Reaffirms the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) as amended, and also reaffirms the 2001 World Trade Organization Doha Declaration on the TRIPS Agreement and Public Health, which recognizes that intellectual property rights should be interpreted and implemented in a manner supportive of the right of Member States to protect public health and, in particular, to promote access to medicines for all, and notes the need for appropriate incentives in the development of new health products; 16. Calls upon Member States to enhance and build constructive engagement and stronger partnership with relevant stakeholders from the public and private sectors, civil society and academia to pursue access to universal health coverage by improving the availability, affordability and efficiency of health products through increasing transparency of prices of medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based therapies and other health technologies across the value chain, including through improved regulations, in accordance with national and regional legal frameworks and contexts, to addr ess the global concern about the high prices of some health products, and in this regard encourages the World Health Organization to continue its efforts to biennially convene the Fair Pricing Forum with Member States and all relevant stakeholders to discuss the affordability and transparency of prices and costs relating to health products as one of the fundamental features of a robust health system based on universal health coverage; 17. Also calls upon Member States to explore ways to consider integrating, as appropriate, safe and evidence-based traditional and complementary medicine services within national and/or subnational health systems, particularly at the level of primary health care, according to national context and priorities; 18. Stresses the critical importance of monitoring the indirect impacts of the COVID-19 pandemic on integrated service delivery as well as maintaining the essential part of health-care delivery and global supply chains during the pandemic, including prevention and treatment services for communicable diseases, management of emergency health conditions, provision of medication, supplies and support from health-care workers for the ongoing management of non-communicable diseases, including mental health conditions, and auxiliary services; 19. Calls upon Member States to scale up efforts to strengthen health information systems and collect quality, timely and reliable data, including vital statistics, disaggregated by income, sex, age, race, ethnicity, migratory status, disability, geographical location and other characteristics relevant in national contexts as required to monitor progress and identify gaps in the universal and inclusive achievement of the health-related Sustainable Development Goals, while protecting the privacy of data that could be linked to individuals, and to ensure that the statistics are used to support evidence-based health sector planning, monitor the impacts of the COVID-19 pandemic on health service supply and demand, and facilitate progress towards the achievement of universal health coverage, in line with the 2030 Agenda for Sustainable Development; 17 __________________ 17 20-17079 Resolution 70/1. 7/9